Personalized phospholipase A2 receptor antibody-driven rituximab treatment strategy in membranous nephropathy. Delafosse M, Ponlot E, Esteve E, Ghislain L, et al. Kidney Int 2021;99:1023-1024.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Delafosse M, Ponlot E, Esteve E, Ghislain L, et al. Personalized phospholipase A2 receptor antibody-driven rituximab treatment strategy in membranous nephropathy. Kidney Int 2021;99:1023-1024.
PMID: 33745532